𝔖 Bobbio Scriptorium

✦ LIBER ✦

Potential drug interactions associated with treatments for Type 2 diabetes and its comorbidities: a clinical pharmacology review

✍ Scribed by Freeman, Jeffrey S; Gross, Benjamin

Book ID: 118053447
Publisher: Expert Reviews
Year: 2012
Tongue: English
Weight: 430 KB
Volume: 5
Category: Article
ISSN: 1751-2433
DOI: 10.1586/ecp.11.64

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A new drug target for treatment of dysli

A new drug target for treatment of dyslipidaemia associated with type 2 diabetes and the metabolic syndrome?

✍ Rossitza P Naoumova; D John Betteridge 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 56 KB

Polypharmacy in people with Type 1 and T

Polypharmacy in people with Type 1 and Type 2 diabetes is justified by current guidelines-a comprehensive assessment of drug prescriptions in patients needing inpatient treatment for diabetes-associated problems

✍ Bauer, S.; Nauck, M. A. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 291 KB

Type 2 diabetes as a risk factor for Alz

Type 2 diabetes as a risk factor for Alzheimer’s disease: A meta-analysis and systematic review of the confounders, interactions and neuropathology associated with this relationship

✍ Vagelatos, Nicholas; Eslick, Guy 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 218 KB

[RSC Drug Discovery] New Therapeutic Str

[RSC Drug Discovery] New Therapeutic Strategies for Type 2 Diabetes Volume 74 || Chapter 11. The Discovery and Development of MB07803, a Second-Generation Fructose-1,6-bisphosphatase Inhibitor with Improved Pharmacokinetic Properties, as a Potential Treatment of Type 2 Diabetes

✍ Jones, Rob M 📂 Article 📅 2012 🏛 Royal Society of Chemistry ⚖ 720 KB